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EFFECT OF DIET AND EXERCISE-INDUCED WEIGHT REDUCTION
ON COMPLEMENT REGULATORY PROTEINS CD55 AND CD59
LEVELS IN OVERWEIGHT CHINESE ADOLESCENTS
Ru Wang, Peijie Chen, Wenhe Chen
Department of Sports Medicine, Shanghai University of Sport, Shanghai, CHINA
Recent studies have suggested that complement plays an important role in adipose tissue homeostasis and
insulin resistance, but the involvement of complement regulatory (CReg) proteins in obesity has not been
elucidated. In this study, we examined whether weight reduction induced changes in the levels of the CReg
proteins CD55 (decay accelerating factor) and CD59 (membrane attack complex inhibitory factor) on blood
cells, before and after a 4-week diet and physical exercise intervention. Fourteen overweight Chinese adoles-
cents with a body mass index > 25 kg·(m2)−1 were enrolled, 12 of whom completed the study. CD55 and
CD59 levels on cell surfaces were assessed by flow cytometry. It was observed that anthropometric parame-
ters, serum lipid levels, and glycemic-related factors improved significantly post-intervention. On all cells, the
CD59 level was significantly increased post-intervention, while the CD55 level on lymphocytes and neu-
trophils was significantly decreased post-intervention. The pre-intervention CD55 level on lymphocytes posi-
tively correlated with the pre-intervention percent body fat (r = 0.737, p < 0.01). This correlation remained
significant (r = 0.737, p < 0.01) post-intervention. In conclusion, these observations show that a 4-week diet
and exercise program in overweight Chinese adolescents improved physical characteristics, anthropometric
parameters, serum lipid levels, and glycemic-related factors. The CD55 level on lymphocytes correlates with
percent body fat. Therefore, adipose-derived factors may constitute possible targets for ameliorating over-
weight and obesity and its adverse metabolic consequences. [ J Exerc Sci Fit • Vol 9 • No 1 • 46–51 • 2011]
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Introduction
The prevalence of overweight [body mass index (BMI)
≥ 25 kg·(m2)−1] and obesity [BMI ≥ 30 kg·(m2)−1] has
steadily increased worldwide and is associated with
higher risks for cardiovascular and type 2 diabetes
(Balkau et al. 2007). In 2007–2008, 68% of US adults
were overweight, almost 34% of whom were obese
(Flegal et al. 2010), and 17%of school-aged US children
are obese (Ogden et al. 2010). If this trend were to 
continue, about half of the US population will meet the
criteria for obesity (Stewart et al. 2009). Notably, over-
weight and obesity in children and adolescents is a
growing global concern.
Developing countries, such as China, are following
suit as they urbanize and westernize. Estimates from
the 2002 China National Nutrition and Health Survey
indicate that nearly 215 million Chinese are affected,
about 22% of adults, 5% of children aged 0–6 years,
and 7% of those aged 7–17 years (Wu et al. 2002).
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Preventing obesity in childhood and adolescents is
therefore crucial (Wu et al. 2009).
Globally, obesity is at least in part responsible for
the rising incidence of metabolic disease in adult and
pediatric populations (Nathan & Moran 2008). Adipose
tissue stores excess energy in the form of lipids and
plays important endocrine roles in both physiological
and pathophysiological conditions (Rajala & Scherer
2003). Adipocytes, for example, secret complement
components and complement factors that are part 
of the innate immune system (Halberg et al. 2008). In
addition, a correlation between serum complement
levels and changes in body mass has been reported
(Pomeroy et al. 1997).
Human tissues and cells are generally resistant to
homologous complement because of the action of the
membrane complement regulatory proteins (CReg 
proteins), including decay-accelerating factor (CD55) and
membrane inhibitor of reactive lysis (CD59) (Meri &
Jarva 1998). CD55 and CD59 are widely expressed 
on human blood cells, including leukocytes and ery-
throcytes, and protect these cells from autologous
complement-mediated lysis. The serum C3 level is
related with glucose and lipid metabolism, e.g., LDL-
cholesterol and triglyceride concentrations (Ylitalo et al.
1997). Mice that do not produce C3 are resistant to
diet-induced weight gain (Rajala & Scherer 2003).
Because CReg proteins play a role in regulating com-
plement lysis (Bodian et al. 1997; Nicholson-Weller &
Wang 1994) and because levels of complement pro-
tein are determined by body mass changes (Pomeroy
et al. 1997), we postulate that a correlation exists
between CD55 and CD59 levels and body mass. Thus,
the focus of this study was to evaluate a putative corre-
lation between CD55 and CD59 levels and body mass
specifically by means of a clinical study conducted in 
a population of Chinese obese adolescents.
Methods
Study participants
Individuals with a body mass index (BMI) ≥ 25kg·(m2)−1
are typically defined as “overweight” whereas those
with a BMI ≥ 30 kg·(m2)−1 are typically defined as
obese (Wu et al. 2009). Participants were excluded if
their BMI was less than 25 kg·(m2)−1 and/or if they had
concomitant renal, hepatic, or cardiac disease, and/or if
they were being treated with drugs that could affect the
variables of the study. Two recruited Chinese adolescents
did not complete the study; 12 participants (7 female,
5 male) completed the study. Assays and measurements
were carried out 2 days before (“pre-intervention”) and
2 days after (“post-intervention”) the 4-week diet and
exercise intervention. Participants’ parents signed
informed consents and the protocol was approved by
the institutional review board and in compliance with
The Code of Ethics of the World Medical Association
(Declaration of Helsinki).
Diet and exercise protocol
All participants received well-defined and balanced
meals every day of the 4-week intervention. The
amount of food given met the basal metabolic rate
requirement measures using the Mifflin equation
(Mifflin et al. 1990), recommended to estimate resting
energy expenditure in overweight and obese individu-
als (Weijs 2008). Dietary recommendations must be
individualized according to their own basal metabolic
rate. The prescribed diet represented on an average
2,000 kcal·day−1 and included important nutrients such
as vitamins, minerals, essential amino acids, fiber, 
and polyunsaturated fatty acids. A protein-sparing, low-
energy diet provided 2–3 g protein per kg per day. All
participants also performed an intense exercise pro-
gram (6 d·wk−1, twice daily, for 2 hours per session),
consisting of swimming (intensity: 6 METs), aerobic
exercise (intensity: 7.5 METs), and basketball (intensity:
6 METs). MET values were established using pulmonary
function equipment according to the manufacturer’s
instructions (Cosmed K4b2; COSMED srl, Rome, Italy).
Oxygen consumption (V
.
O2) for all activities was mea-
sured using the Cosmed K4b2 (COSMED srl) portable
metabolic system. Expired respiratory gases were col-
lected on a breath-by-breath basis during a submaximal
treadmill (H/P/Cosmos Pulsar 4.0; h/p/cosmos sports &
medical gmbh, Nussdorf-Traunstein, Germany) test.
Participants started exercise at a speed of 2 km·hr−1,
increased 1 km·hr−1 every 2.5 minutes until 8 km·hr−1
was reached, without a slope gradient on the treadmill.
Eighty percent of the maximum heart rate (HRmax)
was set as standard of exercise termination, during
which V
.
O2 and HR data were collected. Trained research
assistants recorded HR and power output data at the
end of each stage. Based on these values, our previous
work has developed individual linear regression equa-
tions predicting V
.
O2 (Li et al. 2010). Oxygen uptake
values (Ml × kg−1 × min−1) were converted to units of
energy expenditure (METs) by dividing by 3.5 (1 MET
is defined as resting metabolic rate which is 3.5 mL).
HR was measured by palpation every 30 minutes 
during exercise.
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Anthropometric variables
Body mass and height were measured using a digital
scale (Yaohua Weighing System Co., Shanghai, China)
and a wall-mounted stadiometer (TANITA, Tokyo, Japan),
respectively. Body composition (i.e., percent body fat)
was estimated using an impedance analyzer (TANITA)
following the manufacturer’s instructions. Skinfold thick-
ness was measured using callipers (ZiLang Apparatus
Company, Nantong, China) at two sites (i.e., subscapular
and hip). Systolic and diastolic blood pressures were
measured using a sphygmomanometer (Nishimoto
Sangyo Co., Tokyo, Japan), and anthropometric variables
were obtained using a nonelastic flexible rule (Pacific
Measuring Tool Manufacture Co., Beijing, China).
Blood analyses
Blood samples (2mL) were obtained after a 12-hour fast,
pre- and post-intervention. Serum glucose and lipids
were determined as previously described (Anderson 
et al. 1999). Hemoglobin A1C was measured by ion-
exchange HPLC (Bio-Rad, Hercules, CA, USA) according
to the manufacturer’s instructions. Insulin was mea-
sured using an enzyme immunoassay method (Tosoh,
Tokyo, Japan).
Erythrocytes were assessed for cell surface CD55
and CD59 protein level using indirect immunofluores-
cence assays and flow cytometry. Briefly, whole blood
0.5-mL aliquots were mixed with 3 mL of Alsever’s
solution (Sigma-Aldrich Company Ltd., Gillingham,
Dorset, UK) to preserve red blood cells. Cell concentra-
tions were determined using a cell counting chamber
(Paul Marienfeld GmbH & Co. KG, Lauda-konigshofen,
Germany). Erythrocytes (5 × 106) were washed and
incubated for 20 minutes at room temperature with anti-
CD59-fluorescein isothiocyanate (FITC) and anti-CD55-
phycoerythrin (PE) monoclonal antibody (Beckman
Coulter, Brea, CA, USA). Cells were washed again and
analyzed using an EPICS XL flow cytometer (Beckman
Coulter) with proprietary software. Erythrocytes were
gated based on forward log and side scatter log
(Christmas et al. 2006). For leukocytes, 100-μL whole
blood aliquots were subjected to erythrocyte lysis with
OptiLyse C Lysing Solution (Beckman Coulter), and
then the cells were washed. Cells were labeled with
20 μL antibody conjugate for 20 minutes at room tem-
perature. Cells were washed after staining and then
analyzed using an EPICS XL flow cytometer (Beckman
Coulter). Lymphocytes, monocytes, or neutrophils were
gated based on forward and side scatter (Christmas 
et al. 2006). Erythrocytes and leukocytes were incubated
in parallel with isotype-matched control antibodies.
IgG1 (Mouse)-PE mAb and IgG2a-FITC (Mouse) mAb were
used as CD55 and CD59 isotype control, respectively.
Cells labeled with isotype-controls were used so < 1%
of cells labeled with isotype-control antibodies were
positive. Mean fluorescence intensities (MFI) were
recorded for CReg protein-labeling in each subpopula-
tion (Christmas et al. 2006).
Statistical analyses
Data are presented as mean ± standard deviation, and
paired Student t tests were used to assess differences
between variables pre- and post-intervention. Relation-
ships between two-measurement variables were as-
sessed using Pearson’s product moment correlations,
and simple linear regression analysis was used to esti-
mate the independent contribution of percent body fat
to the CD55 protein level on lymphocytes in response
to weight reduction. A value of p < 0.05 was considered
statistically significant. SPSS version 11.5 J (SPSS Inc.,
Chicago, IL, USA), was used for all analyses.
Results
Upon completion of the 4-week diet and exercise pro-
gram, participants exhibited a significant decrease in
body mass, BMI, percent body fat, basal HR, and all
body shape indices tested (except chest circumfer-
ence) (Table 1), as well as serum lipids (except HDLC),
glucose, and insulin levels (Table 2). The CD59 level on
erythrocytes and lymphocytes significantly increased
post-intervention, while the CD55 level on lympho-
cytes and neutrophils significantly decreased. Differ-
ences between the CD55 levels on erythrocytes and
monocytes pre- and post-intervention were not signifi-
cant (Table 2).
Correlations between CReg levels on various cells
and other indices (e.g., body mass, BMI, percent body
fat, basal HR, all body shape indices, serum lipid, and
glucose and insulin levels) were determined. A signifi-
cant correlation was observed between the CD55 
level on lymphocytes and the percent body fat pre-
intervention (r = 0.737, p < 0.01) and post-intervention
(r = 0.737, p < 0.01) (Figure). Correlations remained
significant after adjustment for body mass. Regression
analysis suggested that the percent body fat is a pre-
dictor of the CD55 level on lymphocytes (Figure). A sig-
nificant correlation between the CD59 levels and any
change in anthropometric and metabolic parameters
resulting from the intervention in overweight adoles-
cents was not observed (data not shown).
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Discussion
In the current study, changes in anthropometric param-
eters, serum lipid levels, and glycemic-related factors
showed that post-intervention, whole body adiposity
reduced, and body shape altered to be closer to that of
healthy individuals, observations that are supported by
other reports (Misigoj-Durakovic´ & Durakovic´ 2009).
Our results on the interaction between CD55 protein
level and obesity differ from those reported by Liu et al.
Table 1. Subject characteristics, pre- and post-intervention (n = 12)*
Pre-intervention Post-intervention
Age (yr) 15.1 ± 3.6 Not applicable
Body mass (kg) 87.3 ± 22.3 80.3 ± 20.5†
BMI [kg·(m2)−1] 31.5 ± 5.2 28.8 ± 4.9†
Body fat (%) 41.7 ± 6.8 34.6 ± 6.4†
Systolic blood pressure (mmHg) 104.8 ± 10.3 103.3 ± 13.4
Diastolic blood pressure (mmHg) 58.3 ± 6.0 58.4 ± 5.3
Basal heart rate (d·min−1) 91.6 ± 11.1 81.0 ± 14.2‡
Neck circumference (cm) 34.7 ± 3.4 32.4 ± 3.4†
Chest circumference (cm) 88.2 ± 26.9 89.7 ± 10.4
Waist circumference (cm) 93.8 ± 16.3 84.7 ± 15.7†
Hip circumference (cm) 105.1 ± 10.4 96.2 ± 11.2†
Thigh circumference (cm) 63.6 ± 6.7 57.0 ± 6.7†
Calf circumference (cm) 40.5 ± 3.8 38.6 ± 3.6†
Upper arm tense circumference (cm) 30.9 ± 4.2 28.4 ± 4.2†
Upper arm relax circumference (cm) 30.3 ± 4.1 27.7 ± 4.0†
Shoulder blade skinfold thickness (mm) 30.3 ± 6.7 22.7 ± 5.4†
Hip skinfold thickness (mm) 31.9 ± 4.6 24.6 ± 4.0†
Waist/hip ratio 0.89 ± 0.95 0.88 ± 0.10§
*Data are presented as mean ± standard deviation; significant differences from pre-intervention values are indicated: †p < 0.001; ‡p < 0.01; 
§p < 0.05.
Table 2. Participant blood sample analysis results and CReg changes, pre- and post-intervention (n = 12)*
Pre-intervention Post-intervention
Blood sample analysis
Total RBC count (×1012·L−1) 4.7 ± 0.3 4.4 ± 0.3†
Total WBC count (×109·L−1) 8.9 ± 1.7 6.0 ± 1.2‡
TG (mmol·L−1) 1.3 ± 0.8 0.8 ± 0.3§
TC (mmol·L−1) 4.4 ± 1.0 3.6 ± 0.7‡
HDLC (mmol·L−1) 1.2 ± 0.2 1.1 ± 0.2
LDLC (mmol·L−1) 2.8 ± 0.8 2.1 ± 0.5‡
HBA1C (%) 4.4 ± 0.4 4.2 ± 0.2
GLU (mmol·L−1) 5.3 ± 1.1 4.4 ± 0.5†
Insulin (μIU·mL−1) 23.1 ± 16.2 9.3 ± 2.7§
CReg changes
RBC CD59(MFI) 10.7 ± 0.6 12.4 ± 1.0‡
RBC CD55(MFI) 3.0 ± 0.2 3.1 ± 0.2
LY CD59(MFI) 7.5 ± 0.5 10.8 ± 1.7‡
LY CD55(MFI) 6.6 ± 0.9 5.7 ± 0.8‡
MO CD59(MFI) 19.6 ± 3.3 22.7 ± 4.7§
MO CD55(MFI) 10.8 ± 2.5 9.7 ± 1.8
GR CD59(MFI) 136.2 ± 27.5 201.1 ± 51.2‡
GR CD55(MFI) 5.6 ± 1.5 4.5 ± 1.3§
*Data are presented as mean ± standard deviation; significant differences from pre-intervention values are indicated: †p < 0.01; ‡p < 0.001; 
§p < 0.05. TG = triglyceride; TC = total cholesterol; HDLC = high-density lipoprotein cholesterol; LDLC = low-density lipoprotein cholesterol;
HBA1C = hemoglobin A1c; GLU = glucose; RBC = red blood cell; WBC = white blood cell; LY = lymphocyte; MO = monocyte; GR = neutrophil.
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(2005), who observed that CD55 levels were lower in
patients with hyperlipidemia. Based on our observa-
tions, intervention reduced the CD55 level on lym-
phocytes and neutrophils, and a significant positive
correlation between percent body fat and the CD55
level on lymphocytes, pre- and post-intervention, was
observed. It is likely that the discrepancy between
both results lies in the selection of the study popula-
tion as we enrolled overweight adolescents without
hyperlipidemia in contrast to Liu et al. (2005) who
studied hyperlipidemia patients. However, Leung et al.
(2009) showed in mouse models that CD55 deficiency
leads to increased aortal lipid depositions. Herein, we
also investigated the relationship between CD55 level
and percent body fat by regression analysis, and found
that the coefficient for pre-intervention (0.737) was
close to that for post-intervention (0.737). The CD55
level on lymphocytes correlates with percent body fat.
While weight reduction reduced the CD55 level, it
led to an increase in the CD59 level. The difference
between CD55 and CD59 protein levels may be attrib-
uted to their functions at two different levels in the
complement pathway. CD55 inhibits the assembly of
C3 and C5 convertases, thereby regulating the comple-
ment cascade at the C3 step, while CD59 interferes
with the assembly of the membrane attack complex
C5b-9. The upregulation of CD55 in obese patients
could contribute to the regulation of the complement
cascade at the C3 step. The decrease in whole body
adiposity lowered the CD55 protein level, but not
CD59. In contrast, weight reduction lowered the CD59
protein level, which may not be directly related to the
changes in body mass (Liu et al. 2005). Besides pro-
tecting cells from autologous complement-mediated
lysis, CReg protein can also influence the proliferative
capacity of T-cells, and are an important link between
the innate and the adaptive immune systems. Thus,
immune function changes caused by the decrease in
CD55 might be compensated for by an increase in
CD59. The increase in CReg protein CD59 on the surface
of leukocytes and erythrocytes might modulate T-cell
activation by processes independent of complement
activation (Owuor et al. 2008).
While the study presented herein is limited by the
relatively small participant number, we demonstrated
through statistically relevant data that the C55 and
C59 levels correlate with percent body fat pre- and
post-intervention in Chinese overweight adolescents.
The study also confirms that most likely a combina-
tion of diet and exercise may be effective in reducing
obesity in adolescents; however, the study design does
not allow one to conclude whether either diet or exer-
cise or both caused the beneficial effects observed.
Therefore, a similar study needs to be run with partici-
pants who are put on a diet only, participants who
conduct exercise only, and participants who are sub-
ject to a combined diet and exercise intervention.
Interestingly, it has been demonstrated that dieting
was more effective in reducing weight while physical
exercise was more effective in reducing fat during the
early phase of a weight-reducing program in a popula-
tion of healthy adults (Tsai et al. 2003). Note that the
physical exercise program applied herein was intense
(6 d·wk−1, twice daily, for 2 hours per session). In this
respect, it would be valuable to evaluate whether a less
intense physical exercise program run over a longer time
period would result in a similar effect. Additional studies
are currently being conducted using a wider range of
patients who participate in a diet and physical exercise
program over a longer period of time to evaluate, in part,
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Fig. Correlation and linear regression analysis between CD55 levels on lymphocytes and percent body fat (n =12) pre-intervention
(A) and post-intervention (B). A significant correlation (p < 0.01) was observed using Pearson’s product moment correlations.
The correlation for pre-intervention (0.737) was the same as that for post-intervention (0.737). The coefficient and p are 0.157
and 0.000 for pre-intervention, and 0.167 and 0.000 for post-intervention, respectively, by linear regression analysis.
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whether benefits are sustained during a longer time
span and even after completion of the intervention. In
addition, the connection between the CD55 level on
lymphocytes and adipocyte metabolism needs further
scrutiny.
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